Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50


Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent.

Kristensen LE, Alten R, Puig L, Philipp S, Kvien TK, Mangues MA, van den Hoogen F, Pavelka K, Vulto AG.

BioDrugs. 2018 Oct;32(5):397-404. doi: 10.1007/s40259-018-0306-1.


Nutritional recommendations for gout: An update from clinical epidemiology.

Nielsen SM, Zobbe K, Kristensen LE, Christensen R.

Autoimmun Rev. 2018 Sep 10. pii: S1568-9972(18)30209-X. doi: 10.1016/j.autrev.2018.05.008. [Epub ahead of print] Review.


Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: A prospective cohort study.

Højgaard P, Ellegaard K, Nielsen SM, Christensen R, Guldberg-Møller J, Ballegaard C, Dreyer L, Mease P, de Wit M, Skov L, Glintborg B, Bliddal H, Bartels EM, Amris K, Kristensen LE.

Arthritis Care Res (Hoboken). 2018 Jul 5. doi: 10.1002/acr.23693. [Epub ahead of print]


The Parker Model: Applying a Qualitative Three-Step Approach to Optimally Utilize Input from Stakeholders When Introducing New Device Technologies in the Management of Chronic Rheumatic Diseases.

Jørgensen TS, Skougaard M, Taylor PC, Asmussen HC, Lee A, Klokker L, Svejstrup L, Mountian I, Gudbergsen H, Kristensen LE.

Patient. 2018 Oct;11(5):515-526. doi: 10.1007/s40271-018-0306-8.


Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies.

Alinaghi F, Calov M, Kristensen LE, Gladman DD, Coates LC, Jullien D, Gottlieb AB, Gisondi P, Wu JJ, Thyssen JP, Egeberg A.

J Am Acad Dermatol. 2018 Jun 18. pii: S0190-9622(18)32149-2. doi: 10.1016/j.jaad.2018.06.027. [Epub ahead of print] Review.


Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers.

Højgaard P, Ballegaard C, Cordtz R, Zobbe K, Clausen M, Glintborg B, Kristensen LE, Dreyer L.

Rheumatology (Oxford). 2018 Sep 1;57(9):1651-1660. doi: 10.1093/rheumatology/key140.


Patient reported outcomes more important than objective inflammatory markers for sick leave in biologics-treated rheumatoid arthritis patients.

Olofsson T, Söderling JK, Gülfe A, Kristensen LE, Wallman JK.

Arthritis Care Res (Hoboken). 2018 Jun 8. doi: 10.1002/acr.23619. [Epub ahead of print]


Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example.

Chatzidionysiou K, Hetland ML, Frisell T, Di Giuseppe D, Hellgren K, Glintborg B, Nordström D, Aaltonen K, Törmänen MR, Klami Kristianslund E, Kvien TK, Provan SA, Björn Guðbjörnsson B, Dreyer L, Kristensen LE, Jørgensen TS, Jacobsson L, Askling J.

RMD Open. 2018 Apr 12;4(1):e000655. doi: 10.1136/rmdopen-2018-000655. eCollection 2018. Review. Erratum in: RMD Open. 2018 May 14;4(1):.


Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers.

Cordtz RL, Hawley S, Prieto-Alhambra D, Højgaard P, Zobbe K, Overgaard S, Odgaard A, Kristensen LE, Dreyer L.

Ann Rheum Dis. 2018 May;77(5):684-689. doi: 10.1136/annrheumdis-2017-212424. Epub 2017 Dec 15.


Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study.

Dreyer L, Cordtz RL, Hansen IMJ, Kristensen LE, Hetland ML, Mellemkjaer L.

Ann Rheum Dis. 2018 Apr;77(4):510-514. doi: 10.1136/annrheumdis-2017-212086. Epub 2017 Dec 7.


Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis.

Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, Kvien TK, Luger T, McHugh N, Mease P, Nash P, Ogdie A, Rosen CF, Strand V, Tillett W, Veale DJ, Helliwell PS.

Arthritis Rheumatol. 2018 Mar;70(3):345-355. doi: 10.1002/art.40391. Epub 2018 Feb 6.


Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study using Danish healthcare registers.

Cordtz RL, Zobbe K, Højgaard P, Kristensen LE, Overgaard S, Odgaard A, Lindegaard H, Dreyer L.

Ann Rheum Dis. 2018 Feb;77(2):281-288. doi: 10.1136/annrheumdis-2017-212339. Epub 2017 Nov 2.


Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population-Based Cohort Study.

Ballegaard C, Højgaard P, Dreyer L, Cordtz R, Jørgensen TS, Skougaard M, Tarp S, Kristensen LE.

Arthritis Care Res (Hoboken). 2018 Apr;70(4):592-599. doi: 10.1002/acr.23333. Epub 2018 Mar 7.


Impact of age and sex on the incidence and prevalence of psoriatic arthritis.

Egeberg A, Kristensen LE.

Ann Rheum Dis. 2018 Apr;77(4):e19. doi: 10.1136/annrheumdis-2017-211980. Epub 2017 Aug 1. No abstract available.


Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study.

Andreasen RA, Kristensen LE, Ellingsen T, Christensen R, Baraliakos X, Wied J, Aalykke C, Ulstrup T, Schiøttz-Christensen B, Horn HC, Emamifar A, Duerlund B, Fischer L, Hansen IMJ.

BMJ Open. 2017 Jul 10;7(7):e015536. doi: 10.1136/bmjopen-2016-015536.


Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study.

Egeberg A, Kristensen LE, Thyssen JP, Gislason GH, Gottlieb AB, Coates LC, Jullien D, Gisondi P, Gladman DD, Skov L, Mallbris L.

Ann Rheum Dis. 2017 Sep;76(9):1591-1597. doi: 10.1136/annrheumdis-2016-210963. Epub 2017 May 8.


Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.

Lie E, Lindström U, Zverkova-Sandström T, Olsen IC, Forsblad-d'Elia H, Askling J, Kapetanovic MC, Kristensen LE, Jacobsson LTH.

Ann Rheum Dis. 2017 Sep;76(9):1515-1521. doi: 10.1136/annrheumdis-2016-210931. Epub 2017 Mar 2.


EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.

Jørgensen TS, Turesson C, Kapetanovic M, Englund M, Turkiewicz A, Christensen R, Bliddal H, Geborek P, Kristensen LE.

PLoS One. 2017 Feb 2;12(2):e0169946. doi: 10.1371/journal.pone.0169946. eCollection 2017.


Work Disability in Newly Diagnosed Patients with Primary Sjögren Syndrome.

Mandl T, Jørgensen TS, Skougaard M, Olsson P, Kristensen LE.

J Rheumatol. 2017 Feb;44(2):209-215. doi: 10.3899/jrheum.160932. Epub 2016 Nov 15.


Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study.

Kristensen LE, Jørgensen TS, Christensen R, Gudbergsen H, Dreyer L, Ballegaard C, Jacobsson LTH, Strand V, Mease PJ, Kjellberg J.

Ann Rheum Dis. 2017 Sep;76(9):1495-1501. doi: 10.1136/annrheumdis-2016-210579. Epub 2017 Jan 30.


Increased mortality in patients with severe COPD associated with high-intensity exercise: a preliminary cohort study.

Schaadt L, Christensen R, Kristensen LE, Henriksen M.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 26;11:2329-2334. eCollection 2016.


The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries.

Højgaard P, Glintborg B, Kristensen LE, Gudbjornsson B, Love TJ, Dreyer L.

Rheumatology (Oxford). 2016 Dec;55(12):2191-2199. Epub 2016 Sep 19.


Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden.

Wallman JK, Eriksson JK, Nilsson JÅ, Olofsson T, Kristensen LE, Neovius M, Geborek P.

J Rheumatol. 2016 Jul;43(7):1292-9. doi: 10.3899/jrheum.150617. Epub 2016 Jun 1.


Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.

Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, Feltelius N, Hetland ML, Askling J; ARTIS Study Group, For the DANBIO Study Group.

Ann Rheum Dis. 2017 Jan;76(1):105-111. doi: 10.1136/annrheumdis-2016-209270. Epub 2016 May 4.


Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: protocol for a prospective, exploratory cohort study.

Højgaard P, Christensen R, Dreyer L, Mease P, de Wit M, Skov L, Glintborg B, Christensen AW, Ballegaard C, Bliddal H, Bukhave K, Bartels EM, Amris K, Ellegaard K, Kristensen LE.

BMJ Open. 2016 Apr 15;6(4):e010650. doi: 10.1136/bmjopen-2015-010650.


Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden.

Einarsson JT, Geborek P, Saxne T, Kristensen LE, Kapetanovic MC.

J Rheumatol. 2016 Jun;43(6):1017-23. doi: 10.3899/jrheum.150995. Epub 2016 Apr 1.


Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers.

Lindström U, Forsblad-d'Elia H, Askling J, Kristensen LE, Lie E, Exarchou S, Jacobsson L.

Arthritis Res Ther. 2016 Jan 19;18:16. doi: 10.1186/s13075-016-0917-1.


Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden.

Kristensen LE, Lie E, Jacobsson LT, Christensen R, Mease PJ, Bliddal H, Geborek P.

J Rheumatol. 2016 Jan;43(1):81-7. doi: 10.3899/jrheum.150744. Epub 2015 Dec 1.


Mortality in ankylosing spondylitis: results from a nationwide population-based study.

Exarchou S, Lie E, Lindström U, Askling J, Forsblad-d'Elia H, Turesson C, Kristensen LE, Jacobsson LT.

Ann Rheum Dis. 2016 Aug;75(8):1466-72. doi: 10.1136/annrheumdis-2015-207688. Epub 2015 Sep 2.


Work Disability in Early Systemic Sclerosis: A Longitudinal Population-based Cohort Study.

Sandqvist G, Hesselstrand R, Petersson IF, Kristensen LE.

J Rheumatol. 2015 Oct;42(10):1794-800. doi: 10.3899/jrheum.150023. Epub 2015 Aug 1.


Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.

Jørgensen TS, Kristensen LE, Christensen R, Bliddal H, Lorenzen T, Hansen MS, Østergaard M, Jensen J, Zanjani L, Laursen T, Butt S, Dam MY, Lindegaard HM, Espesen J, Hendricks O, Kumar P, Kincses A, Larsen LH, Andersen M, Næser EK, Jensen DV, Grydehøj J, Unger B, Dufour N, Sørensen V, Vildhøj S, Hansen IM, Raun J, Krogh NS, Hetland ML.

Rheumatology (Oxford). 2015 Dec;54(12):2156-65. doi: 10.1093/rheumatology/kev216. Epub 2015 Jul 13.


The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study.

Exarchou S, Lindström U, Askling J, Eriksson JK, Forsblad-d'Elia H, Neovius M, Turesson C, Kristensen LE, Jacobsson LT.

Arthritis Res Ther. 2015 May 9;17:118. doi: 10.1186/s13075-015-0627-0.


The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.

Lie E, Kristensen LE, Forsblad-d'Elia H, Zverkova-Sandström T, Askling J, Jacobsson LT; ARTIS Study Group.

Ann Rheum Dis. 2015 Jun;74(6):970-8. doi: 10.1136/annrheumdis-2014-206616. Epub 2015 Feb 20.


Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.

Forsblad-d'Elia H, Bengtsson K, Kristensen LE, Jacobsson LT.

Rheumatology (Oxford). 2015 Jul;54(7):1186-93. doi: 10.1093/rheumatology/keu455. Epub 2014 Dec 13.


Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects.

Jakobsen AK, Jacobsson LT, Patschan O, Askling J, Kristensen LE.

PLoS One. 2014 Nov 25;9(11):e113602. doi: 10.1371/journal.pone.0113602. eCollection 2014.


Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register.

Chatzidionysiou K, Askling J, Eriksson J, Kristensen LE, van Vollenhoven R; ARTIS group.

Ann Rheum Dis. 2015 May;74(5):890-6. doi: 10.1136/annrheumdis-2013-204714. Epub 2014 Jan 15.


Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Kapetanovic MC, Kristensen LE, Saxne T, Aktas T, Mörner A, Geborek P.

Arthritis Res Ther. 2014 Jan 2;16(1):R2. doi: 10.1186/ar4427.


The prevalence of moderate to severe radiographic sacroiliitis and the correlation with health status in elderly Swedish men--the MrOS study.

Exarchou S, Redlund-Johnell I, Karlsson M, Mellström D, Ohlsson C, Turesson C, Kristensen LE, Jacobsson L.

BMC Musculoskelet Disord. 2013 Dec 13;14:352. doi: 10.1186/1471-2474-14-352.


Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort.

Kristensen LE, Bliddal H, Christensen R, Karlsson JA, Gülfe A, Saxne T, Geborek P.

Arthritis Care Res (Hoboken). 2014 Feb;66(2):173-9. doi: 10.1002/acr.22107.


Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study.

Kristensen LE, Englund M, Neovius M, Askling J, Jacobsson LT, Petersson IF.

Ann Rheum Dis. 2013 Oct;72(10):1675-9. doi: 10.1136/annrheumdis-2012-202229. Epub 2012 Nov 12.


National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.

Karlsson JA, Nilsson JÅ, Neovius M, Kristensen LE, Gülfe A, Saxne T, Geborek P.

Ann Rheum Dis. 2011 Dec;70(12):2163-6. doi: 10.1136/ard.2011.153437. Epub 2011 Aug 22.


Utility-based outcomes made easy: the number needed per quality-adjusted life year gained. An observational cohort study of tumor necrosis factor blockade in inflammatory arthritis from Southern Sweden.

Gülfe A, Kristensen LE, Saxne T, Jacobsson LT, Petersson IF, Geborek P.

Arthritis Care Res (Hoboken). 2010 Oct;62(10):1399-406. doi: 10.1002/acr.20235.


Open access publishing. And now, e-publication bias.

Jakobsen AK, Christensen R, Persson R, Bartels EM, Kristensen LE.

BMJ. 2010 Apr 28;340:c2243. doi: 10.1136/bmj.c2243. No abstract available.


[The efficacy of the three available anti-tumour necrosis factor therapies in patients with rheumatoid arthritis. A meta-analytic literature review--secondary publication].

Christensen R, Kristensen LE, Geborek P, Danneskiold-Samsøe B, Saxne T, Bliddal H.

Ugeskr Laeger. 2009 Jun 22;171(26):2192-4. Review. Danish.


Six and 12 weeks treatment response predicts continuation of tumor necrosis factor blockade in rheumatoid arthritis: an observational cohort study from southern Sweden.

Gülfe A, Kristensen LE, Geborek P.

J Rheumatol. 2009 Mar;36(3):517-21. doi: 10.3899/jrheum.080509. Epub 2009 Jan 22.


[Severe hypothermia].

Kristensen LE, Larssen-Aas F.

Ugeskr Laeger. 2003 Nov 3;165(45):4295-6. Danish. No abstract available.


Supplemental Content

Loading ...
Support Center